Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma
Expert Review of Anticancer Therapy · 02.01.2026 · 26 (1) · 81-92
DOI: 10.1080/14737140.2025.2575017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Anticancer Therapy, online erschienen am 14.10.2025. Verfasst von Dev Kashyap und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, ISF College of Pharmacy, Moga, India. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Hepatocellular carcinoma (HCC), a common and aggressive liver cancer, frequently manifests at an advanced stage, restricting the effectiveness of standard treatments. Recent advancements in nanotechnology, particularly in liposome-based delivery systems, offer promising approaches to enhance treatment efficacy and immunological regulation in hepatocellular carcinoma (HCC). AREAS COVERED: This study emphasizes the diverse functions of liposomes in augmenting drug solubility, targeting neoplastic tissues, increasing immunological responses, and surmounting biological barriers. It investigates the synergy of liposomal platforms and immunotherapies, including checkpoint inhibitors, and their incorporation with locoregional treatments for advanced-stage hepatocellular carcinoma (HCC). EXPERT OPINION: Liposomes are a revolutionary approach in cancer immunotherapy. Innovations like PEGylation, surface ligand modification, and dual-drug encapsulation have significantly enhanced treatment outcomes in preclinical and early clinical contexts. Advancements, especially in patient-specific and stimuli-responsive systems, may transform the future of HCC care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Quality Assurance, ISF College of Pharmacy, Moga, India.
- Department of Pharmaceutics, ISF College of Pharmacy, Moga, India.
- Department of Pharmacy, ISF College of Pharmacy, Moga, India.
- Department of Pharmaceutics, School of Pharmacy, Chandigarh University, Unnao, U.P, India.
- Department of Pharmaceutics, MM College of Pharmacy, MM(DU), Ambala, India.
- Gurukul Institute of Pharmaceutical Sciences, Fatehgarh Sahib, India.
Zitieren
APA
Kashyap, D., Kumar, M., Singh, A., Kansal, A., Kaur, A., Srivastava, S., Saini, V., & Kour, J. (2026). Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma. Expert Review of Anticancer Therapy, 26(1), 81-92. https://doi.org/10.1080/14737140.2025.2575017
Vancouver
Kashyap D, Kumar M, Singh A, Kansal A, Kaur A, Srivastava S, et al. Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma. Expert Review of Anticancer Therapy. 2026;26(1):81-92. doi:10.1080/14737140.2025.2575017
BibTeX
@article{Kashyap2026,
author = {Kashyap, Dev and Kumar, Manish and Singh, Ayush and Kansal, Arnav and Kaur, Amanpreet and Srivastava, Shruti and Saini, Vipin and Kour, Jagpreet},
title = {Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma},
journal = {Expert Review of Anticancer Therapy},
year = {2026},
volume = {26},
number = {1},
pages = {81--92},
doi = {10.1080/14737140.2025.2575017}
}
EUVIMED